Related Experiment Video
Updated: Jun 28, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
A review of anti-parasitic patents (1988-2008)
1Parasitology Department, Institute of Medicine Tropical "Pedro Kourí", Havana City, Cuba. monzote@ipk.sld.cu
Abstract:
New anti-parasitic drugs are urgently needed to treat and control diseases such as malaria, leishmaniasis, sleeping sickness, filariasis and schistosomiasis, which affect millions of people each year. In this review, we are focusing on patents of anti-parasitic agents that have been published during the last 20 years, from 01/1988 to 04/2008. The data collected demonstrate that the number of patents concerning this issue has been increasing. In addition, the reports for antiprotozoan compounds are more numerous when compared with anthelminths drugs. The synthetic products were the most patented, following of natural ones and combination of existing drugs. The discovery of new antiparasitic drugs to obtain a solution to million of people who suffer and die due to parasitic diseases is an urgent need.
Related Concept Videos
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Immunoprecipitation
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...

